No abstract available
Keywords:
artificial intelligence; bioinformatics (computational biopharmaceutics and modeling); metabolic diseases; natural compounds; network pharmacology; pharmaceutical chemistry.
Grants and funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The work was supported by the National Natural Science Foundation of China (No. 62131004), and the National Key R&D Program of China (2022ZD0117700).